Researchers have developed a way to communicate with human neurons through biochemical interactions, taking neurological medicine beyond the current limits of electrical impulse communication.
Administering two types of immunotherapy drugs concurrently has paused or reversed malignant tumor growth in almost sixty percent of patients participating in a UK clinical trial.
Edmond J. LaVoie, PhD, Professor and Chair of the Department of Medicinal Chemistry at Rutgers University, discusses the potential of a new antibiotic to combat the increasing problems…
Each year, more than one and a half million women in the United States undergo a breast biopsy. After a breast biopsy, a pathologist evaluates the tissue to…
Alan Russell, PhD, Professor at Carnegie Mellon University, explains some of the obstacles of regenerative medicine, one of which being that cells injected into the body don’t inherently…
Tory Williams, author of Inevitable Collision discusses her new book which chronicles the Geron Trials, focusing on the stories of two patients who participated in the study. The book includes…
Katie Sharify, a participant in the world’s first human embryonic stem cell trial, describes the accident that qualified her for this groundbreaking study, and her decision to participate.…
Yaron Daniely, PhD, MBA, CEO of Alcobra Pharma talks about MDX, which, if approved, will be the first therapy of its kind for Fragile X Syndrome, the orphan disease…
Kourosh Parsapour, MD, MBA, talks about how to improve patient education, engagement, and compliance through an informative and simple app, PersonalRN (pRN). PersonalRN is a virtual health coach…